ipamorelin cjc 1295 no dac 5mg 5mg CJC-1295 without + IPA Ipamorelin/CJC-1295 (no DAC) 5MG/5MG |

Preclinical and in vitro studies describe it as a compound capable of stimulating pulsatile GH release without significantly altering other endocrine axes, such as ACTH, prolactin, FSH, LH, TSH, or cortisol

Includes dosing protocols, timing strategies & results timeline

Steroid-refractory colitis, myocarditis 12 and pneumonitis 13 have been described, and are characterised by high mortality rates and significant uncertainty regarding optimal management strategies

Mocetti P

In May 2016, Aleksey Lovchev has been banned for four years after failing A and B-samples, where he was tested positively for ipamorelin, a hormone growth drug